Cocrystal Pharma (COCP) Receivables (2010 - 2020)
Cocrystal Pharma (COCP) posted Receivables of $1.1 million for Q4 2020, down 4.3% sequentially from $1.2 million in Q3 2020, and down 13.66% YoY from $1.3 million in Q1 2020.
Cocrystal Pharma (COCP) Receivables (2010 - 2020) Analysis & Trends
Cocrystal Pharma has reported Receivables for 10 years, with the latest figure at $1.1 million in Q4 2020.
- Quarterly Receivables fell 13.66% year-over-year to $1.1 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $1.1 million (down 13.66% YoY) and the FY2020 annual result came in at $1.1 million, down 13.66% from the prior year.
- Receivables slipped to $1.1 million in Q4 2020 per COCP's latest filing, from $1.2 million in the prior quarter.
- Over five years, Receivables peaked at $1.8 million in Q2 2019 and troughed at $13000.0 in Q2 2016.
- A 4-year average of $1.0 million and a median of $1.2 million in 2020 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 550.99% in 2016, down 89.04% in 2016.
- Over 4 years, Receivables stood at $1.3 million in 2016, then slipped by 1.52% to $1.3 million in 2017, then decreased by 0.54% to $1.3 million in 2019, then declined by 13.66% to $1.1 million in 2020.
- According to Business Quant data, Receivables over the past three periods registered $1.1 million, $1.2 million, and $1.2 million for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Cocrystal Pharma | 16.27 Mn | 13.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.11 Mn |
| Sep 30, 2020 | 1.16 Mn |
| Jun 30, 2020 | 1.18 Mn |
| Mar 31, 2020 | 1.29 Mn |
| Dec 31, 2019 | 1.29 Mn |
| Sep 30, 2019 | 1.54 Mn |
| Jun 30, 2019 | 1.83 Mn |
| Mar 31, 2019 | 1.08 Mn |
| Dec 31, 2017 | 1.30 Mn |
| Dec 31, 2016 | 1.32 Mn |
| Sep 30, 2016 | 16,000.00 |
| Jun 30, 2016 | 13,000.00 |
| Mar 31, 2016 | 16,000.00 |
| Dec 31, 2015 | 202,000.00 |
| Sep 30, 2015 | 12,000.00 |
| Jun 30, 2015 | 17,000.00 |
| Mar 31, 2015 | 146,000.00 |
| Dec 31, 2014 | 287,000.00 |
| Sep 30, 2013 | 400,000.00 |
| Jun 30, 2013 | 1.49 Mn |